GlassScriptPhysician profile
Taylor E Hobson
NPI 1104357763
$73,713.43
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,841 · 2020: $87.71 · 2021: $1,420 · 2022: $29K · 2023: $19K · 2024: $9,982 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $22K · Food and Beverage: $13K · Education: $6,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,822.57 |
| Food and Beverage | $12,921.34 |
| Education | $6,201.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,879.84 | 2022-2024 | Arthrex |
| Smith+Nephew, INC. | $18,400.63 | 2022-2025 | Q-Fix, Novostitch, Healicoil |
| Stryker Corporation | $14,880.43 | 2019-2025 | Salvation, Gamma, Mako |
| Medical Device Business Services, INC. | $4,509.73 | 2019-2023 | Dynacord |
| Zimmer Biomet Holdings, INC. | $2,568.22 | 2023-2025 | Comprehensive Shoulder System, Tapestry, Ncb |
| Rock Medical Orthopedics, INC. | $2,432.38 | 2022 | |
| Shoulder Innovations, INC. | $2,378.07 | 2023-2024 | Inset System |
| Encore Medical, LP | $2,064.63 | 2023-2025 | Djo Surgical |
| Moximed, INC | $1,905.82 | 2025 | Misha Knee System, Small, Left |
| Depuy Synthes Sales INC. | $483.29 | 2022-2023 | Milagro, Dynacord, Fms |
| Saxum Surgical, INC. | $384.37 | 2023-2025 | |
| Djo, LLC | $281.60 | 2023 | Donjoy, Aircast |
| Innovation Technologies INC | $175.47 | 2021-2024 | Irrisept |
| Globus Medical, INC. | $128.27 | 2023-2025 | Anthem, Troch Nail |
| Vericel Corporation | $65.60 | 2023 | Maci |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $56.23 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $54.62 | 2025 | |
| Heron Therapeutics, INC. | $23.64 | 2024 | Zynrelef |
| Ferring Pharmaceuticals INC. | $22.58 | 2025 | Euflexxa |
| Dynasplint Systems INC. | $18.01 | 2025 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Hobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.